Functional proteomics and its application in biomedical sciences

Current Topics in Human Genetics: Studies in Complex Diseases

Volumn , Issue , 2007, Pages 449-462

  Xiao, Guishan ^a,b   Zhang, Teri ^b  

^a HUNAN NORMAL UNIVERSITY   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84967350802     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1142/9789812790811_00017     Document Type: Chapter

References (132)

1. Crameri R, Schulz-Knappe P, Zucht HD. (2005) The future of post-genomic biology at the proteomic level: an outlook. Comb Chem High Throughput Screen 8:807-810.
2. Xiao G, Wang M, Li N, et al. (2003) Use of proteomics to demonstrate a hierarchical oxidative stress macrophage cell line. J Biol Chem 278:50781-50790.
3. Xiao GG, Nel AE, Loo JA. (2005) Nitrotyrosine-modified proteins and oxidative stress induced by diesel exhaust particles. Electrophoresis 26:280-292.
4. Alaiya A, Al-Mohanna M, Linder S. (2005) Clinical cancer proteomics:promises and pitfalls. J Proteome Res 4:1213-1222.
5. Wang MZ, Howard B, Campa MJ, et al. (2003) Analysis of human serum proteins by liquid phase isoelectric focusing and matrix-assisted laser desorption/ionization-mass spectrometry. Proteomics 3:1661-1666.
6. Zheng X, Baker H, Hancock WS. (2006) Analysis of the low molecular weight serum peptidome using ultrafiltration and a hybrid ion trap-Fourier transform mass spectrometer. J Chromatogr A 1120:173-184.
7. Magueijo V, Semiao V, Norberta de Pinho M. (2005) Fluid flow and mass transfer modelling in lysozyme ultrafiltration. Int J Heat Mass Transf 48:1716-1726.
8. Hansson SF, Puchades M, Blennow K, et al. (2004) Validation of a prefractionation method followed by two-dimensional electrophoresis - applied to cerebrospinal fluid proteins from frontotemporal dementia patients. Proteome Sci 2:7.
9. Puchades M, Hansson SF, Nilsson CL, et al. (2003) Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer’s disease. Brain Res Mol Brain Res 118:140-146.
10. Harper RG, Workman SR, Schuetzner S, et al. (2004) Low-molecular-weight human serum proteome using ultrafiltration, isoelectric focusing, and mass spectrometry. Electrophoresis 25:1299-1306.
11. Hesse C, Nilsson CL, Blennow K, Davidsson P. (2001) Identification of the apolipoprotein E4 isoform in cerebrospinal fluid with preparative twodimensional electrophoresis and matrix assisted laser desorption/ionization- time of flight-mass spectrometry. Electrophoresis 22:1834-1837.
12. Davidsson P, Paulson L, Hesse C, et al. (2001) Proteome studies of human cerebrospinal fluid and brain tissue using a preparative two-dimensional electrophoresis approach prior to mass spectrometry. Proteomics 1:444-452.
13. Davidsson P, Westman A, Puchades M, et al. (1999) Characterization of proteins from human cerebrospinal fluid by a combination of preparative two-dimensional liquid-phase electrophoresis and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Anal Chem 71:642-647.
14. Puchades M, Westman A, Blennow K, Davidsson P. (1999) Analysis of intact proteins from cerebrospinal fluid by matrix-assisted laser desorption/ionization mass spectrometry after two-dimensional liquid-phase electrophoresis. Rapid Commun Mass Spectrom 13:2450-2455.
15. Davidsson P, Folkesson S, Christiansson M, et al. (2002) Identification of proteins in human cerebrospinal fluid using liquid-phase isoelectric focusing as a prefractionation step followed by two-dimensional gel electrophoresis and matrix-assisted laser desorption/ionisation mass spectrometry. Rapid Commun Mass Spectrom 16:2083-2088.
16. Westman-Brinkmalm A, Davidsson P. (2002) Comparison of preparative and analytical two-dimensional electrophoresis for isolation and matrixassisted laser desorption/ionization-time-of-flight mass spectrometric analysis of transthyretin in cerebrospinal fluid. Anal Biochem 301:161-167.
17. Thoren K, Gustafsson E, Clevnert A, et al. (2002) Proteomic study of nontypable Haemophilus influenzae. J Chromatogr B Analyt Technol Biomed Life Sci 782:219-226.
18. Covert BA, Spencer JS, Orme IM, Belisle JT. (2001) The application of proteomics in defining the T cell antigens of Mycobacterium tuberculosis. Proteomics 1:574-586.
19. Gustafsson E, Thoren K, Larsson T, et al. (2001) Identification of proteins from Escherichia coli using two-dimensional semi-preparative electrophoresis and mass spectrometry. Rapid Commun Mass Spectrom 15:428-432.
20. Nilsson CL, Larsson T, Gustafsson E, et al. (2000) Identification of protein vaccine candidates from Helicobacter pylori using a preparative twodimensional electrophoretic procedure and mass spectrometry. Anal Chem 72:2148-2153.
21. Janini GM, Conrads TP, Veenstra TD, Issaq HJ. (2003) Development of a two-dimensional protein-peptide separation protocol for comprehensive proteome measurements. J Chromatogr B 787:43-51.
22. Lubman DM, Kachman MT, Wang H, et al. (2002) Two-dimensional liquid separations - mass mapping of proteins from human cancer lysates. J Chromatogr B 782:183-196.
23. Wang H, Kachman MT, Schwartz DR, et al. (2002) A protein molecular weight map of ES2 clear cell ovarian carcinoma cells using a two-dimensional liquid separations/mass mapping technique. Electrophoresis 23:3168-3181.
24. Wall DB, Parus SJ, Lubman DM. (2002) Three-dimensional protein map according to pI, hydrophobicity and molecular mass. J Chromatogr B 774:53-58.
25. Kachman MT, Wang H, Schwartz DR, et al. (2002) A 2-D liquid separations/mass mapping method for interlysate comparison of ovarian cancers. Anal Chem 74:1779-1791.
26. Gong Y, Li X, Yang B, et al. (2006) Different immunoaffinity fractionation strategies to characterize the human plasma proteome. J Proteome Res 5:1379-1387.
27. Gorg A, Weiss W, Dunn MJ. (2004) Current two-dimensional electrophoresis technology for proteomics. Proteomics 4:3665-3685.
28. Rabilloud T. (2002) Two-dimensional gel electrophoresis in proteomics: old, old fashioned, but it still climbs up the mountains. Proteomics 2:3-10.
29. O’Farrell PH. (1975) High resolution two-dimensional electrophoresis of proteins. J Biol Chem 250:4007-4021.
30. Klose J, Kobalz U. (1995) Two-dimensional electrophoresis of proteins: an updated protocol and implications for a functional analysis of the genome. Electrophoresis 16:1034-1059.
31. Park OK. (2004) Proteomic studies in plants. J Biochem Mol Biol 37:133-138.
32. Gorg A, Obermaier C, Boguth G, et al. (1997) Very alkaline immobilized pH gradients for two-dimensional electrophoresis of ribosomal and nuclear proteins. Electrophoresis 18:328-337.
33. Somiari RI, Somiari S, Russell S, Shriver CD. (2005) Proteomics of breast carcinoma. J Chromatogr B 815:215-225.
34. Boyle WJ, Smeal T, Defize LH, et al. (1991) Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity. Cell 64:573-584.
35. Corthals GL, Aebersold R, Goodlett DR. (2005) Identification of phosphorylation sites using microimmobilized metal affinity chromatography. Methods Enzymol 405:66-81.
36. Friedman DB, Hill S, Keller JW, et al. (2004) Proteome analysis of human colon cancer by two-dimensional difference gel electrophoresis and mass spectrometry. Proteomics 4:793-811.
37. Alban A, David SO, Bjorkesten L, et al. (2003) A novel experimental design for comparative two-dimensional gel analysis: two-dimensional difference gel electrophoresis incorporating a pooled internal standard. Proteomics 3:36-44.
38. Chiari M, Micheletti C, Nesi M, et al. (1994) Towards new formulations for polyacrylamide matrices: N-acryloylaminoethoxyethanol, a novel monomer combining high hydrophilicity with extreme hydrolytic stability. Electrophoresis 15:177-186.
39. Pennington K, McGregor E, Beasley CL, et al. (2004) Optimization of the first dimension for separation by two-dimensional gel electrophoresis of basic proteins from human brain tissue. Proteomics 4:27-30.
40. Bae SH, Harris AG, Hains PG, et al. (2003) Strategies for the enrichment and identification of basic proteins in proteome projects. Proteomics 3:569-579.
41. Barry RC, Alsaker BL, Robison-Cox JF, Dratz EA. (2003) Quantitative evaluation of sample application methods for semipreparative separations of basic proteins by two-dimensional gel electrophoresis. Electrophoresis 24:3390-3404.
42. Zhu K, Miller FR, Barder TJ, Lubman DM. (2004) Identification of low molecular weight proteins isolated by 2-D liquid separations. J Mass Spectrom 39:770-780.
43. Zhang Z, Smith DL, Smith JB. (2001) Multiple separations facilitate identification of protein variants by mass spectrometry. Proteomics 1:1001-1009.
44. Davis MT, Beierle J, Bures ET, et al. (2001) Automated LC-LC-MSMS platform using binary ion-exchange and gradient reversed-phase chromatography for improved proteomic analyses. J Chromatogr B Biomed Sci Appl 752:281-291.
45. Lubman DM, Kachman MT, Wang H, et al. (2002) Two-dimensional liquid separations - mass mapping of proteins from human cancer cell lysates. J Chromatogr B Analyt Technol Biomed Life Sci 782:183-196.
46. Shin YK, Lee HJ, Lee JS, Paik YK. (2006) Proteomic analysis of mammalian basic proteins by liquid-based two-dimensional column chromatography. Proteomics 6:1143-1150.
47. Chong BE, Yan F, Lubman DM, Miller FR. (2001) Chromatofocusing nonporous reversed-phase high-performance liquid chromatography/electrospray ionization time-of-flight mass spectrometry of proteins from human breast cancer whole cell lysates: a novel two-dimensional liquid chromatography/mass spectrometry method. Rapid Commun Mass Spectrom 15:291-296.
48. Wall DB, Kachman MT, Gong S, et al. (2000) Isoelectric focusing nonporous RP HPLC: a two-dimensional liquid-phase separation method for mapping of cellular proteins with identification using MALDI-TOF mass spectrometry. Anal Chem 72:1099-1111.
49. Wall DB, Kachman MT, Gong SS, et al. (2001) Isoelectric focusing nonporous silica reversed-phase high-performance liquid chromatography/electrospray ionization time-of-flight mass spectrometry: a threedimensional liquid-phase protein separation method as applied to the human erythroleukemia cell-line. Rapid Commun Mass Spectrom 15:1649-1661.
50. Shin YK, Lee HJ, Lee JS, Paik YK. (2006) Proteomic analysis of mammalian basic proteins by liquid-based two-dimensional column chromatography. Proteomics 6:1143-1150.
51. Westermeier R, Gronau S, Becket P, et al. (2005) A guide to methods and applications of DNA and protein separations. In: Electrophoresis in Practice, 4th ed., Westermeier R (ed.), Wiley-VCH Verlag, Weinheim, Germany.
52. Hardy E, Santana H, Sosa A, et al. (1996) Recovery of biologically active proteins detected with imidazole-sodium dodecyl sulfate-zinc (reverse stain) on sodium dodecyl sulfate gels. Anal Biochem 240:150-152.
53. Merril CR, Switzer RC, Van Keuren ML. (1979) Trace polypeptides in cellular extracts and human body fluids detected by two-dimensional electrophoresis and a highly sensitive silver stain. Proc Natl Acad Sci USA 76:4335-4339.
54. Mackintosh JA, Choi HY, Bae SH, et al. (2003) A fluorescent natural product for ultra sensitive detection of proteins in one-dimensional and twodimensional gel electrophoresis. Proteomics 3:2273-2288.
55. Berggren KN, Schulenberg B, Lopez MF, et al. (2002) An improved formulation of SYPRO Ruby protein gel stain: comparison with the original formulation and with a ruthenium II tris (bathophenanthroline disulfonate) formulation. Proteomics 2:486-498.
56. Steinberg TH, Pretty On Top K, Berggren KN, et al. (2001) Rapid and simple single nanogram detection of glycoproteins in polyacrylamide gels and on electroblots. Proteomics 1:841-855.
57. Somiari R. (2005) Proteomics of breast carcinoma. J Chromatogr B 815:215-225.
58. Graves PR, Haystead TAJ. (2002) Molecular biologist’s guide to proteomics. Microbiol Mol Biol Rev 66:39-63.
59. Porath J, Carlsson J, Olsson I, Belfrage G. (1975) Metal chelate affinity chromatography, a new approach to protein fractionation. Nature 258:598-599.
60. Washburn MP, Wolters D, Yates JR 3rd. (2001) Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat Biotechnol 19:242-247.
61. Link AJ, Eng J, Schieltz DM, et al. (1999) Direct analysis of protein complexes using mass spectrometry. Nat Biotechnol 17:676-682.
62. Fliser D, Wittke S, Mischak H. (2005) Capillary electrophoresis coupled to mass spectrometry for clinical diagnostic purposes. Electrophoresis 26:2708-2716.
63. Covey TR, Devanand P. (2002) Nanospray electrospray ionization development:LC/MS, CE/MS application. In: Applied Electrospray Mass Spectrometry, Practical Spectroscopy Series, Vol. 32, Pramanik BN, Ganguly AK, Gross ML (eds.), Marcel Dekker, New York, NY.
64. Zheng X, Baker H, Hancock WS. (2006) Analysis of the low molecular weight serum peptidome using ultrafiltration and a hybrid ion trap-Fourier transform mass spectrometer. J Chromatogr A 1120:173-184.
65. Medzihradszky KF, Campbell JM, Baldwin MA, et al. (2000) The characteristics of peptide collision-induced dissociation using a high-performance MALDI-TOF/TOF tandem mass spectrometer. Anal Chem 72:552-558.
66. Guerrara I, Kleiner O. (2005) Application of mass spectrometry in proteomics. Biosci Rep 25:71-93.
67. Schweitzer B, Predki P, Snyder M. (2003) Microarrays to characterize protein interactions on a whole-proteome scale. Proteomics 3:2190-2199.
68. Kersten B, Feilner T, Kramer A, et al. (2003) Generation of Arabidopsis protein chips for antibody and serum screening. Plant Mol Biol 52:999-1010.
69. Tonkinson JL, Osborn DS, Zhao WW, Stillman BA. (2003) Development of microscale immunoassays for parallel analysis of multiple analytes. IVD Technol 2:29-34.
70. Wulfkuhle JD, Aquino JA, Calverts VS, et al. (2003) Signal pathway profiling of ovarian cancer from human tissue specimens using reverse-phase protein microarrays. Proteomics 3:2085-2090.
71. Espejo A, Cote J, Bednarek A, et al. (2002) A protein-domain microarray identifies novel protein-protein interactions. Biochem J 367:697-702.
72. White AM, Daly DS, Varnum SM, et al. (2006) ProMAT: protein microarray analysis tool. Bioinformatics 22:1278-1279.
73. Hoheisel JD. (2006) Microarray technology: beyond transcript profiling and genome type analysis. Nat Rev Genet 7:200-210.
74. Tusher VG, Tibshirani R, Chu G. (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98:5116-5121.
75. Hedenfalk I, Duggan D, Chen Y, et al. (2001) Gene-expression profiles in hereditary breast cancer. N Engl J Med 344:539-548.
76. Van Belle W, Anensen N, Haaland I, et al. (2006) Correlation analysis of two-dimensional gel electrophoretic protein patterns and biological variables. BMC Bioinformatics 7:198.
77. Kaplan N, Linial M. (2005) Automatic detection of false annotations via binary property clustering. BMC Bioinformatics 6:46.
78. Duncan MW, Hunsucker SW. (2005) Proteomics as a tool for clinically relevant biomarker discovery and validation. Exp Biol Med 230:808-817.
79. Alexander H, Stegner AL, Wagner-Mann C, et al. (2004) Proteomic analysis to identify breast cancer biomarkers in nipple aspirate fluid. Clin Cancer Res 10:7500-7510.
80. Wu S, Kim J, Hancock WS, Karger S. (2005) Extended Range Proteomic Analysis (ERPA): a new and sensitive LC-MS platform for high sequence coverage of complex proteins with extensive post-translational modifications - comprehensive analysis of beta-casein and epidermal growth factor receptor (EGFR). J Proteome Res 4:1155-1170.
81. Bergman AC, Benjamin T, Alaiya A, et al. (2000) Identification of gelseparated tumor marker proteins by mass spectrometry. Electrophoresis 21:679-686.
82. Shannon WD, Watson MA, Perry A, Rich K. (2002) Mantel statistics to correlate gene expression levels from microarrays with clinical covariates. Genet Epidemiol 23:87-96.
83. Bafna V, Edwards N. (2001) SCOPE: a probabilistic model for scoring tandem mass spectra against a peptide database. Bioinformatics 17(Suppl 1):S13-S21.
84. Low TY, Seow TK, Chung MC. (2002) Separation of human erythrocyte membrane associated proteins with one-dimensional and two-dimensional gel electrophoresis followed by identification with matrix-assisted laser desorption/ionization-time of flight mass spectrometry. Proteomics 2:1229-1239.
85. Kakhniashvili DG, Bulla LA Jr, Goodman SR. (2004) The human erythrocyte proteome: analysis by ion trap mass spectrometry. Mol Cell Proteomics 3:501-509.
86. Korbel S, Buchse T, Prietzch H, et al. (2005) Phosphoprotein profiling of erythropoietin receptor-dependent pathways using different proteomic strategies. Proteomics 5:91-100.
87. Thadikkaran L, Siegenthaler M, Crettaz D, et al. (2005) Recent advances in blood-related proteomics. Proteomics 5:3019-3034.
88. Garcia A, Watson S, Dwek R, Zitzmann N. (2005) Applying proteomics technology to platelet research. Mass Spectrom Rev 24:918-930.
89. Von Bruchhausen F, Walter U. (1997) Platelets and Their Factors. Springer-Verlag, Berlin, Germany.
90. O’Neill EE, Brock CJ, von Kriegshiem AF, et al. (2002) Towards complete analysis of the platelet proteome. Proteomics 2:288-305.
91. Garcia A, Zitzmann N, Watson SP. (2004) Analyzing the platelet proteome. Semin Thromb Hemost 30:485-489.
92. Geveart K, Van Damme J, Goethals M, et al. (2002) Chromatographic isolation of methionine-containing peptides for gel-free proteome analysis. Mol Cell Proteomics 1:896-903.
93. Anderson NL, Anderson NG. (2002) The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 1:845-867.
94. Chan KC, Lucas DA, Hise D, et al. (2004) Analysis of the human serum proteome. Clin Proteomics 1:101-226.
95. Watanabe H, Hamada H, Yamada N, et al. (2004) Proteome analysis reveals elevated serum levels of clusterin in patients with preeclampsia. Proteomics 4:537-543.
96. Kwak JY, Ma TZ, Yoo MJ, et al. (2004) The comparative analysis of serum proteomes for the discovery of biomarkers for acute myeloid leukemia. Exp Hematol 32:836-842.
97. Chen JH, Chang YW, Yaho CW, et al. (2004) Plasma proteome of severe acute respiratory syndrome analyzed by two-dimensional gel electrophoresis and mass spectrometry. Proc Natl Acad Sci USA 101:17039-17044.
98. Qian WJ, Jacobs JM, Camp DG, et al. (2005) Comparative proteome analyses of human plasma following in vivo lipopolysaccharide administration using multidimensional separations coupled with tandem mass spectrometry. Proteomics 5:572-584.
99. Mandel ID. (1993) Salivary diagnosis: more than a lick and a promise. J Am Dent Assoc 124:85-87; erratum 20-21.
100. Miller SM. (1994) Saliva testing - a nontraditional diagnostic tool. Clin Lab Sci 7:39-44.
101. Li Y, Zhou X, St John MA, Wong DT. (2004) RNA profiling of cell-free saliva using microarray technology. J Dent Res 83:199-203.
102. Li Y, St John MA, Zhou X, et al. (2004) Salivary transcriptome diagnostics for oral cancer detection. Clin Cancer Res 10:8442-8450.
103. Li Y, Denny P, Ho C, et al. (2005) The Oral Fluid MEMS/NEMS Chip (OFMNC): diagnostic and translational applications. Adv Dent Res 18:3-5.
104. Vitzthum F, Behrens F, Anderson L, Shaw J. (2005) Proteomics: from basic research to diagnostic application. A review of requirements and needs. J Proteome Res 4:1086-1097.
105. Zolg JW, Langen H. (2004) How industry is approaching the search for new diagnostic markers and biomarkers. Mol Cell Proteomics 3:345-354.
106. Bell DY, Hook GE. (1979) Pulmonary alveolar proteinosis: analysis of airway and alveolar proteins. Am Rev Respir Dis 119:979-990.
107. Bowler RP, Duda B, Chan ED, et al. (2004) Proteomic analysis of pulmonary edema fluid and plasma in patients with acute lung injury. Am J Physiol Lung Cell Mol Physiol 286:L1086-L1087.
108. Noel-Georis I, Beman A, Falmagne P, Wattiez R. (2002) Database of bronchoalveolar lavage fluid proteins. J Chromatogr B Analyt Technol Biomed Life Sci 771:221-236.
109. Noel-Georis I, Bernard A, Falmagne P, Wattiez R. (2001) Proteomics as the tool to search for lung disease markers in bronchoalveolar lavage. Dis Markers 17:271-284.
110. von Bredow C, Birrer P, Griese M. (2001) Surfactant protein A and other bronchoalveolar lavage fluid proteins are altered in cystic fibrosis. Eur Respir J 17:716-722.
111. Lenz AG, Meyer B, Costabel U, Maier K. (1993) Bronchoalveolar lavage fluid proteins in human lung disease: analysis by two-dimensional electrophoresis. Electrophoresis 14:242-244.
112. Wattiez R, Hermans C, Cruyt C, et al. (2000) Human bronchoalveolar lavage fluid protein two-dimensional database: study of interstitial lung diseases. Electrophoresis 21:2703-2712.
113. Neumann M, von Bredow C, Ratjen F, Griese M. (2002) Bronchoalveolar lavage protein patterns in children with malignancies, immunosuppression, fever and pulmonary infiltrates. Proteomics 2:683-689.
114. Alexander H, Steger A, Wagner-Mann C, et al. (2004) Proteomic analysis to identify breast cancer biomarkers in nipple aspirate fluid. Clin Cancer Res 10:7500-7510.
115. Zhao H, Adler K, Bai C, et al. (2006) Epithelial proteomics in multiple organs and tissues: similarities and variations between cells, organs, and diseases. J Proteome Res 5:743-755.
116. Kondo T, Seike M, Mori Y, et al. (2003) Application of sensitive fluorescent dyes in linkage of laser microdissection and two-dimensional gel electrophoresis as a cancer proteomic study tool. Proteomics 3:1758-1766.
117. Faber MJ, Agnetti G, Bezstarosti K, et al. (2006) Recent developments in proteomics: implications for the study of cardiac hypertrophy and failure. Cell Biochem Biophys 44:11-29.
118. Gey GO, Coffman WD, Kubicek MT. (1952) Tissue culture studies of the proliferative capacity of cervical carcinoma and normal epithelium. Cancer Res 12:264-265.
119. Diaz JI, Cazares LH, Corica A, John Semmes O. (2004) Selective capture of prostatic basal cells and secretory epithelial cells for proteomic and genomic analysis. Urol Oncol 22:329-336.
120. Yingling JM, Blanchard KL, Sawyer JS. (2004) Development of TGFbeta signaling inhibitors for cancer therapy. Nat Rev Drug Discov 3:1011-1022.
121. Schmidt-Weber CB, Blaser K. (2004) Regulation and role of transforming growth factor-beta in immune tolerance induction and inflammation. Curr Opin Immunol 16:709-716.
122. Kanamoto T, Hellman U, Heldin CH, Souchelnytskyi S. (2002) Functional proteomics of transforming growth factor-beta1-stimulated Mv1Lu epithelial cells: Rad51 as a target of TGFbeta1-dependent regulation of DNA repair. EMBO J 21:1219-1230.
123. Paron I, D’Elia A, D’Ambrosio C, et al. (2004) A proteomic approach to identify early molecular targets of oxidative stress in human epithelial lens cells. Biochem J 378:929-937.
124. Nedelkov D. (2005) Population proteomics: addressing protein diversity in humans. Expert Rev Proteomics 2:315-324.
125. Steel LF, Haab BB, Hanash SM. (2005) Methods of comparative proteomic profiling for disease diagnostics. J Chromatogr B Analyt Technol Biomed Life Sci 815:275-283.
126. Villanueva J, Philip J, Entenberg D, et al. (2004) Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry. Anal Chem 76:1560-1570.
127. Zhang X, Leung SM, Morris CR, Shigenaga MK. (2004) Evaluation of a novel, integrated approach using functionalized magnetic beads, bench-top MALDI-TOF-MS with prestructured sample supports, and pattern recognition software for profiling potential biomarkers in human plasma. J Biomol Tech 15:167-175.
128. Stoeckli M, Chaurand P, Hallahan DE, Caprioli RM. (2001) Imagining mass spectrometry: a new technology for the analysis of protein expression in mammalian tissues. Nat Med 7:493-496.
129. Nägele E, Vollmer M, Hörth P, Vad C. (2004) 2D-LC/MS techniques for the identification of proteins in highly complex mixtures. Expert Rev Proteomics 1:37-46.
130. Davis MT, Beierle J, Bures ET, et al. (2001) Automated LC/LC-MS/MS platform using binary ion-exchange and gradient reversed-phase chromatography for improved proteomic analyses. J Chromatogr B Biomed Sci Appl 752:281-291.
131. Peng J, Elias JE, Thoreen CC, et al. (2003) Evaluation of multidimensional chromatography coupled with tandem mass spectrometry (LC/LC-MS/MS) for large-scale protein analysis: the yeast proteome. J Proteome Res 2:43-50.
132. Adkins JN, Varnum SM, Auberry KJ, et al. (2002) Towards a human blood proteome. Mol Cell Proteomics 1:947-955.